Literature DB >> 6885639

A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples.

Y Matsushita, H Iguchi, T Kiyosaki, H Tone, T Ishikura, T Takeuchi, H Umezawa.   

Abstract

A method for measuring 4'-O-tetrahydropyranyladriamycin (THP) and its metabolites in biological samples are described. By reversed-phase high performance liquid chromatography using fluorescence detection, THP and its metabolites were all separated on a single chromatogram within 18 minutes. A linear calibration curve was obtained up to 2,000 ng/ml of THP in plasma. The recovery of THP in the analysis was more than 95% above 5 ng/ml and 87.1% even at 1.25 ng/ml. Thus the lower limit was 1.25 ng/ml in biological samples. Blood levels and urinary excretion in mice and dogs were satisfactory measured by this analytical method.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885639     DOI: 10.7164/antibiotics.36.880

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

1.  Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin).

Authors:  M N Raber; R A Newman; K Lu; S Legha; C Gorski; R S Benjamin; I H Krakoff
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.

Authors:  H Iguchi; H Tone; T Ishikura; T Takeuchi; H Umezawa
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 3.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

4.  Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer.

Authors:  R M Mader; H Zilg; O Schlappack; G G Steger; M Baur; B Greifenberg; U Heberle; C Dittrich
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells.

Authors:  T Yamaoka; M Hanada; S Ichii; S Morisada; T Noguchi; Y Yanagi
Journal:  Jpn J Cancer Res       Date:  1998-10

6.  In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite.

Authors:  T Noguchi; S Ichii; S Morisada; T Yamaoka; Y Yanagi
Journal:  Jpn J Cancer Res       Date:  1998-10

7.  Tumor-selective distribution of an active metabolite of the 9-aminoanthracycline amrubicin.

Authors:  T Noguchi; S Ichii; S Morisada; T Yamaoka; Y Yanagi
Journal:  Jpn J Cancer Res       Date:  1998-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.